8 research outputs found
Poor sensitivity of rapid tests for the detection of antibodies to the hepatitis B virus : implications for field studies
Rapid tests (RTs) can be used as an alternative method for the conventional diagnosis of hepatitis B virus (HBV). This study aims to evaluate antibodies to HBsAg (anti-HBs) and antibodies to HBeAg (anti-HBe) RTs under different Brazilian settings. The following three groups were included: GI: viral hepatitis outpatient services; GII: low resource areas; and GIII: crack users and beauticians. Imuno-rápido anti-HBsAg™ and Imuno-rápido anti-HBeAg™ RTs were evaluated and showed specificities greater than 95% in all groups. The sensitivity values to anti-HBs were 50.38%, 51.05% and 46.73% and the sensitivity values to anti-HBe were 76.99%, 10.34% and 11.76% in the GI, GII and GIII groups, respectively. The assays had a low sensitivity and high specificity, which indicated their use for screening in regions endemic for HBV
"The first shot": the context of first injection of illicit drugs, ongoing injecting practices, and hepatitis C infection in Rio de Janeiro, Brazil
The context of first drug injection and its association with ongoing injecting practices and HCV (hepatitis C virus) infection were investigated. Injection drug users (IDUs) (N = 606) were recruited in "drug scenes" (public places, bars) in Rio de Janeiro, Brazil, interviewed, and tested for HCV. Sharing of needles/syringes was more prevalent at the first injection (51.3%) than at the baseline interview (36.8%). Those who shared syringes/needles at first injection were more likely to be currently engaged in direct/indirect sharing practices. Among young injectors (< 30 years), those reporting sharing of needles/ syringes at the first injection were about four times more likely to have been infected by HCV. Hepatitis C virus prevalence among active IDUs (n = 272) was 11%. Prison history and longer duration of drug injection were identified as independent predictors of HCV infection. To effectively curb HCV transmission among IDUs and minimize harms associated with risk behaviors, preventive strategies should target individuals initiating drug injection beginning with their very first injection and discourage the transition from non-injecting use to the self-injection of illicit drugs
O contexto da primeira injeção de drogas ilícitas, práticas atuais de injeção e infecção pelo vírus da hepatite C no Rio de Janeiro, Brasil
Made available in DSpace on 2010-08-23T16:58:45Z (GMT). No. of bitstreams: 3
license.txt: 1841 bytes, checksum: a5257d71b0356aeff53d32009d34b256 (MD5)
Bastos_The first shot_2006.pdf: 86231 bytes, checksum: f6d2d377f4aa8c4b8cc43719b7d500ba (MD5)
Bastos_The first shot_2006.pdf.txt: 41800 bytes, checksum: 64819703c1789244cc4566aceb885273 (MD5)
Previous issue date: 2006Made available in DSpace on 2010-11-04T14:19:47Z (GMT). No. of bitstreams: 3
Bastos_The first shot_2006.pdf.txt: 41800 bytes, checksum: 64819703c1789244cc4566aceb885273 (MD5)
Bastos_The first shot_2006.pdf: 86231 bytes, checksum: f6d2d377f4aa8c4b8cc43719b7d500ba (MD5)
license.txt: 1841 bytes, checksum: a5257d71b0356aeff53d32009d34b256 (MD5)
Previous issue date: 2006Fundação Oswaldo Cruz. Centro de Informação Científica e Tecnológica. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.Universidade do Estado do Rio de Janeiro. Núcleo de Estudos e Pesquisas em Atenção ao Uso de Drogas. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Centro de Informação Científica e Tecnológica. Rio de Janeiro, RJ, Brasil.O trabalho investiga o contexto da primeira injeção de
drogas e sua associação com práticas atuais de injeção
e infecção pelo HCV (vírus da hepatite C). Usuários de
drogas injetáveis (UDI) (N = 606) foram recrutados em
cenas de uso (ruas, bares) do Rio de Janeiro, Brasil, entrevistados
e testados (anti-HCV). A freqüência de
compartilhamento de agulhas e seringas foi superior
na primeira injeção (51,3%), se comparada à atualmente
referida (36,8%). Usuários que iniciaram o uso
injetável compartilhando agulhas/seringas relataram
uma freqüência significativamente maior de compartilhamento
direto/indireto de agulhas/seringas nos últimos
seis meses. A infecção pelo HCV foi quatro vezes
mais prevalente entre UDI jovens (< 30 anos) que compartilharam
agulhas e seringas na primeira injeção. A
prevalência de anti-HCV foi 11% entre UDI ativos (n =
272) e se mostrou independentemente associada à
história de prisão e à duração do uso de drogas injetáveis.
A prevenção da disseminação do HCV nesta
população requer a adoção de medidas de redução de
riscos e danos associados à injeção de drogas já desde
a primeira injeção ou, antes, um desestímulo à transição
do uso não injetável para injetável.The context of first drug injection and its association
with ongoing injecting practices and HCV
(hepatitis C virus) infection were investigated.
Injection drug users (IDUs) (N = 606) were recruited
in “drug scenes” (public places, bars) in
Rio de Janeiro, Brazil, interviewed, and tested
for HCV. Sharing of needles/syringes was more
prevalent at the first injection (51.3%) than at
the baseline interview (36.8%). Those who
shared syringes/needles at first injection were
more likely to be currently engaged in direct/indirect
sharing practices. Among young injectors
(< 30 years), those reporting sharing of needles/
syringes at the first injection were about four
times more likely to have been infected by HCV.
Hepatitis C virus prevalence among active IDUs
(n = 272) was 11%. Prison history and longer
duration of drug injection were identified as independent
predictors of HCV infection. To effectively
curb HCV transmission among IDUs and
minimize harms associated with risk behaviors,
preventive strategies should target individuals
initiating drug injection beginning with their
very first injection and discourage the transition
from non-injecting use to the self-injection of illicit
drugs
Poor sensitivity of rapid tests for the detection of antibodies to the hepatitis B virus: implications for field studies
Rapid tests (RTs) can be used as an alternative method for the conventional diagnosis of hepatitis B virus (HBV). This study aims to evaluate antibodies to HBsAg (anti-HBs) and antibodies to HBeAg (anti-HBe) RTs under different Brazilian settings. The following three groups were included: GI: viral hepatitis outpatient services; GII: low resource areas; and GIII: crack users and beauticians. Imuno-rápido anti-HBsAg™ and Imuno-rápido anti-HBeAg™ RTs were evaluated and showed specificities greater than 95% in all groups. The sensitivity values to anti-HBs were 50.38%, 51.05% and 46.73% and the sensitivity values to anti-HBe were 76.99%, 10.34% and 11.76% in the GI, GII and GIII groups, respectively. The assays had a low sensitivity and high specificity, which indicated their use for screening in regions endemic for HBV
"The first shot": the context of first injection of illicit drugs, ongoing injecting practices, and hepatitis C infection in Rio de Janeiro, Brazil O contexto da primeira injeção de drogas ilícitas, práticas atuais de injeção e infecção pelo vírus da hepatite C no Rio de Janeiro, Brasil
The context of first drug injection and its association with ongoing injecting practices and HCV (hepatitis C virus) infection were investigated. Injection drug users (IDUs) (N = 606) were recruited in "drug scenes" (public places, bars) in Rio de Janeiro, Brazil, interviewed, and tested for HCV. Sharing of needles/syringes was more prevalent at the first injection (51.3%) than at the baseline interview (36.8%). Those who shared syringes/needles at first injection were more likely to be currently engaged in direct/indirect sharing practices. Among young injectors (< 30 years), those reporting sharing of needles/ syringes at the first injection were about four times more likely to have been infected by HCV. Hepatitis C virus prevalence among active IDUs (n = 272) was 11%. Prison history and longer duration of drug injection were identified as independent predictors of HCV infection. To effectively curb HCV transmission among IDUs and minimize harms associated with risk behaviors, preventive strategies should target individuals initiating drug injection beginning with their very first injection and discourage the transition from non-injecting use to the self-injection of illicit drugs.<br>O trabalho investiga o contexto da primeira injeção de drogas e sua associação com práticas atuais de injeção e infecção pelo HCV (vírus da hepatite C). Usuários de drogas injetáveis (UDI) (N = 606) foram recrutados em cenas de uso (ruas, bares) do Rio de Janeiro, Brasil, entrevistados e testados (anti-HCV). A freqüência de compartilhamento de agulhas e seringas foi superior na primeira injeção (51,3%), se comparada à atualmente referida (36,8%). Usuários que iniciaram o uso injetável compartilhando agulhas/seringas relataram uma freqüência significativamente maior de compartilhamento direto/indireto de agulhas/seringas nos últimos seis meses. A infecção pelo HCV foi quatro vezes mais prevalente entre UDI jovens (< 30 anos) que compartilharam agulhas e seringas na primeira injeção. A prevalência de anti-HCV foi 11% entre UDI ativos (n = 272) e se mostrou independentemente associada à história de prisão e à duração do uso de drogas injetáveis. A prevenção da disseminação do HCV nesta população requer a adoção de medidas de redução de riscos e danos associados à injeção de drogas já desde a primeira injeção ou, antes, um desestímulo à transição do uso não injetável para injetável